EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 2 51-2, 2005, Pages

  Chiu, Terence ^a   Santiskulvong, Chintda ^a   Rozengurt, Enrique ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidermal growth factor receptor; IEC 18 cells; Mitogen activated protein kinase; Mitogen extracellular signal regulated kinase; Phosphatidylinositol 3 kinase; Protein kinase B

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN; BISINDOLYLMALEIMIDE; CALCIUM; DIACYLGLYCEROL; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE 2; ILOMASTAT; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN S6; PROTEIN TYROSINE KINASE; RAPAMYCIN;

ARTICLE; CELL CULTURE; DNA SYNTHESIS; ENZYME INHIBITION; FLOW CYTOMETRY; GENE SILENCING; INTESTINE EPITHELIUM CELL; MITOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; ANIMALS; CELL LINE; CELL PROLIFERATION; DNA; GENE SILENCING; INTESTINAL MUCOSA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS; TRANS-ACTIVATION (GENETICS);

EID: 12344306176     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00200.2004     Document Type: Article

References (57)

1. Agren MS, Mirastschijski U, Karlsmark T, and Saarialho-Kere UK. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 10: 337-348, 2001.
2. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, and Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996.
3. Blume-Jensen P and Hunter T. Oncogenic kinase signalling. Nature 411: 355-365, 2001.
4. Brazil DP and Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664, 2001.
5. Burgess AW. Growth control mechanisms in normal and transformed intestinal cells. Philos Trans R Soc Lond B Biol Sci 353: 903-909, 1998.
6. Carpenter G. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J Cell Biol 146: 697-702, 1999.
7. Chiu T and Rozengurt E. PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am J Physiol Cell Physiol 280: C929-C942, 2001.
8. Chiu T, Santiskulvong C, and Rozengurt E. ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 285:G1-G11, 2003.
9. Chiu T, Wu SS, Santiskulvong C, Tangkijvanich P, Yee HF Jr, and Rozengurt E. Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol 282: C434-C450, 2002.
10. Cunnick JM, Dorsey JF, Standley T, Turkson J, Kraker AJ, Fry DW, Jove R, and Wu J. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem 273: 14468-14475, 1998.
11. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997.
12. Daub H, Weiss FU, Wallasch C, and Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
13. Dugourd C, Gervais M, Corvol P, and Monnot C. Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 41: 882-890, 2003.
14. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, and Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274: 36843-36851, 1999.
15. Feng J, Park J, Cron P, Hess D, and Hemmings B. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-41196, 2004.
16. Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, and Black JD. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 151: 763-778, 2000.
17. Gordon PV, Paxton JB, Herman AC, Carlisle EM, and Fox NS. Igf-I accelerates ileal epithelial cell migration in culture and newborn mice and may be a mediator of steroid-induced maturation. Pediatr Res 55: 34-41, 2004.
18. Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, and Marsigliante S. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol 196: 370-377, 2003.
19. Hama K, Ohnishi H, Yasuda H, Ueda N, Mashima H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, and Sugano K. Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem Biophys Res Commun 315: 905-911, 2004.
20. Hamilton M and Wolfman A. Oncogenic Ha-ras-dependent mitogen-activated protein kinase activity requires signaling through the epidermal growth factor receptor. J Biol Chem 273: 28155-28162, 1998.
21. Hao JL, Nagano T, Nakamura M, Kumagai N, Mishima H, and Nishida T. Effect of galardin on collagen degradation by Pseudomonas aeruginosa. Exp Eye Res 69: 595-601, 1999.
22. Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, and Hanai H. Immunohistochemical localization of angiotensin II receptor and local reninangiotensin system in human colonic mucosa. J Histochem Cytochem 50: 275-282, 2002.
23. Hosoda Y, Winarto A, Iwanaga T, and Kuwahara A. Mode of action of ANG II on ion transport in guinea pig distal colon. Am J Physiol Gastrointest Liver Physiol 278: G625-G634, 2000.
24. Jin XH, Wang ZQ, Siragy HM, Guerrant RL, and Carey RM. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol Regul Integr Comp Physiol 275: R515-R523, 1998.
25. Kalmes A, Vesti BR, Daum G, Abraham JA, and Clowes AW. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87: 92-98, 2000.
26. Kanai M, Mullen C, and Podolsky DK. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci USA 95: 178-182, 1998.
27. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, and Ebina Y. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278: 28312-28323, 2003.
28. Kazanov D, Dvory-Sobol H, Pick M, Liberman E, Strier L, Choen-Noyman E, Deutsch V, Kunik T, and Arber N. Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitro. Clin Cancer Res 10: 267-271, 2004.
29. Keely SJ, Uribe JM, and Barrett KE. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion. J Biol Chem 273: 27111-27117, 1998.
30. Kenerson HL, Aicher LD, True LD, and Yeung RS. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62: 5645-5650, 2002.
31. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, and Robertson JW. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352: 179-184, 1998.
32. Li Y, Corradetti MN, Inoki K, and Guan KL. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci 29: 32-38, 2004.
33. Okano J, Gaslightwala I, Birnbaum MJ, Rustgi AK, and Nakagawa H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J Biol Chem 275: 30934-30942, 2000.
34. Peterson RT, Beal PA, Comb MJ, and Schreiber SL. FKBP12-rapamycin- associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275: 7416-7423, 2000.
35. Polakiewicz RD, Schieferl SM, Dorner LF, Kansra V, and Comb MJ. A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J Biol Chem 273: 12402-12406, 1998.
36. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999.
37. Preston SL, Wong WM, Chan AO, Poulsom R, Jeffery R, Goodlad RA, Mandir N, Elia G, Novelli M, Bodmer WF, Tomlinson IP, and Wright NA. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 63: 3819-3825, 2003.
38. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, and Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science 279: 707-710, 1998.
39. Pullen N and Thomas G. The modular phosphorylation and activation of p70s6k. FEBS Lett 410: 78-82, 1997.
40. Quaroni A, Wands J, Trelstad RL, and Isselbacher KJ. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80: 248-265, 1979.
41. Raab G and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333: F179-199, 1997.
42. Reynolds THt, Bodine SC, and Lawrence JC Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 277: 17657-17662, 2002.
43. Rozengurt E. Early signals in the mitogenic response. Science 234: 161-166, 1986.
44. Rozengurt E. Neuropeptides as cellular growth factors: role of multiple signalling pathways. Eur J Clin Invest 21: 123-134, 1991.
45. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J Cell Physiol 177: 507-517, 1998.
46. Rozengurt E. Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol Metab 13: 128-134, 2002.
47. Rozengurt E and Walsh JH. Gastrin, CCK, signaling and cancer. Ann Rev Physiol 63: 49-76, 2001.
48. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, and Velculescu VE. High frequency of mutations of the PIK3CA gene in human cancers (Abstract). Science 304: 554, 2004.
49. Santibanez JF, Guerrero J, Quintanilla M, Fabra A, and Martinez J. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 296: 267-273, 2002.
50. Santos MF, McCormack SA, Guo Z, Okolicany J, Zheng Y, Johnson LR, and Tigyi G. Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J Clin Invest 100: 216-225, 1997.
51. Soubeyran P, Andre F, Lissitzky JC, Mallo GV, Moucadel V, Roccabianca M, Rechreche H, Marvaldi J, Dikic I, Dagorn JC, and Iovanna JL. Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 117: 1326-1338, 1999.
52. Tsai W, Morielli AD, and Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 16: 4597-4605, 1997.
53. Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, and Avruch J. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J Biol Chem 273: 16621-16629, 1998.
54. Wetzker R and Bohmer FD. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4: 651-657, 2003.
55. Wright NA and Poulsom R. Top down or bottom up? Competing management structures in the morphogenesis of colorectal neoplasms. Gut 51: 306-308, 2002.
56. 2+, PKC, and Rho kinase. Am J Physiol Cell Physiol 282: C1432-C1444, 2002.
57. Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Harashi N, Kawano S, and Hori M. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res 63: 6726-5734, 2003.